1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. OrganiGram Holdings Inc.
  6. Summary
    OGI   CA68620P1018

ORGANIGRAM HOLDINGS INC.

(OGI)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Toronto Stock Exchange
05/16/2022 05/17/2022 05/18/2022 05/19/2022 05/20/2022 Date
1.67(c) 1.73(c) 1.56(c) 1.61(c) 1.54(c) Last
649 202 390 339 1 197 107 614 252 420 024 Volume
+5.03% +3.59% -9.83% +3.21% -4.35% Change
More quotes
Estimated financial data (e)
Sales 2022 134 M 104 M 104 M
Net income 2022 -18,6 M -14,5 M -14,5 M
Net cash position 2022 116 M 90,2 M 90,2 M
P/E ratio 2022 -17,3x
Yield 2022 -
Sales 2023 180 M 140 M 140 M
Net income 2023 -16,9 M -13,2 M -13,2 M
Net cash position 2023 96,5 M 75,2 M 75,2 M
P/E ratio 2023 -21,0x
Yield 2023 -
Capitalization 483 M 376 M 376 M
EV / Sales 2022 2,75x
EV / Sales 2023 2,15x
Nbr of Employees 841
Free-Float 81,3%
More Financials
Company
OrganiGram Holdings Inc. is a Canada-based company, which operates through its subsidiaries, Organigram Inc (Organigram) and Laurentian Organic Inc. Organigram is a licensed producer of cannabis and extract-based products. The Company is focused on producing, indoor-grown cannabis for patients and adult recreational consumers in Canada. Organigram is permitted to possess, produce, sell, provide, ship, deliver and... 
More about the company
Ratings of OrganiGram Holdings Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about ORGANIGRAM HOLDINGS INC.
01:04aCreso Pharma Signs Distribution Deal for Body Care Products in Australia; Shares Rally ..
MT
05/20Entourage Health Climbs 18% as Reaffirms Q1 Preliminary Revenue of $17.4 Million
MT
05/20High Tide Jumps Near 6% as Adds Two Stores, Says Cabana Club Loyalty Program Surpasses ..
MT
05/20Canopy Growth Unveils New Product Line-Up
MT
05/20Pathway Health Q1 Net Loss $0.02 Per Share; Cash Balance Falls; Says in Talks With Top ..
MT
05/20Irwin Naturals Licenses Brand to Larsen Group II in Colorado
MT
05/20Entourage Health Reaffirms Q1 Preliminary Revenue of $17.4 Million; Fell 21% on Thursda..
MT
05/20High Tide Adds Two Stores to Network, Says Cabana Club Loyalty Program Surpasses 515,00..
MT
05/20Kanabo Backs Out Of Materia Acquisition To Pursue Strategic Partnership
MT
05/19Jumbo Interactive Gets Canadian Regulatory Approvals for Lottery Management; Shares Ris..
MT
05/19Trulieve Cannabis Opens Two Medical Dispensary Openings in West Virginia
MT
05/19Bright Green Shares Tumble Amid Elevated Trading Volume
MT
05/19Indiva Q1 Loss $0.02 Per Share Vs Loss $0.03 Year Ago; Net Revenue Increases 44%; Provi..
MT
05/19Little Green Pharma Enters $5.2 Million Cannabis Supply Deal for Germany
MT
05/18Ayr Wellness Details First Sale from Phoenix Cultivation Facility, Launch of STiX Pre-R..
MT
More news
News in other languages on ORGANIGRAM HOLDINGS INC.
01:04aCreso Pharma signe un accord de distribution de produits de soins corporels en Australi..
05/20Entourage Health grimpe de 18 % et confirme un chiffre d'affaires préliminaire de 17,4 ..
05/20High Tide fait un bond de près de 6 % avec l'ajout de deux magasins, le programme de fi..
05/20Canopy Growth dévoile une nouvelle gamme de produits
05/20PATHWAY HEALTH : perte nette de 0,02 $ par action au premier trimestre ; baisse du solde d..
More news
Analyst Recommendations on ORGANIGRAM HOLDINGS INC.
More recommendations
Chart ORGANIGRAM HOLDINGS INC.
Duration : Period :
OrganiGram Holdings Inc. Technical Analysis Chart | OGI | CA68620P1018 | MarketScreener
Technical analysis trends ORGANIGRAM HOLDINGS INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 1,54 CAD
Average target price 3,05 CAD
Spread / Average Target 98,3%
EPS Revisions
Managers and Directors
Beena G. Goldenberg Chief Executive Officer & Director
Derrick W. West Chief Financial Officer
Peter Amirault Executive Chairman
Nathalie Batten Vice President-Operations
Dexter D. S. John Independent Director
Sector and Competitors